COVID-19 variants as moving targets and how to stop them by glycoengineered whole-virus vaccines

by Uri Galili
Published 2021-01-01

Human Natural Antibodies to Mammalian Carbohydrate Antigens as Unsung Heroes Protecting against Past, Present, and Future Viral Infections

by Uri Galili
Published 2020-06-01

Host Synthesized Carbohydrate Antigens on Viral Glycoproteins as “Achilles’ Heel” of Viruses Contributing to Anti-Viral Immune Protection

by Uri Galili
Published 2020-09-01

Conversion of Tumors into Autologous Vaccines by Intratumoral Injection of α-Gal Glycolipids that Induce Anti-Gal/α-Gal Epitope Interaction

by Uri Galili
Published 2011-01-01

Acceleration of Wound Healing by α-gal Nanoparticles Interacting with the Natural Anti-Gal Antibody

by Uri Galili
Published 2015-01-01

In Situ “Humanization” of Porcine Bioprostheses: Demonstration of Tendon Bioprostheses Conversion into Human ACL and Possible Implications for Heart Valve Bioprostheses

by Uri Galili, Kevin R. Stone
Published 2021-01-01

Near Complete Repair After Myocardial Infarction in Adult Mice by Altering the Inflammatory Response With Intramyocardial Injection of α-Gal Nanoparticles

by Uri Galili, Zhongkai Zhu, Jiwang Chen, Josef W. Goldufsky, Gary L. Schaer
Published 2021-08-01

In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal Glycolipids

by Uri Galili, Mark R. Albertini, Paul M. Sondel, Kim Wigglesworth, Mary Sullivan, Giles F. Whalen
Published 2010-05-01

Abstract 135: Anti α-Gal Nanoparticles Ameliorate Radiation-Induced Wound Healing Impairment

by Arash Samadi, Justin buro, Daniel O. Lara, Matthew A. Wright, Uri Galili, Jason A. Spector
Published 2019-04-01